Innovator Warner Chilcott and it’s subsidry Mayne announced (in a press release Here )
that they have filed a second lawsuit against generic player Mylan in the District Court for the District of New Jersey for patent infringement of Orange book listed patent US6958161 (Expiry: Dec 15, 2022) for submission of an Abbreviated New Drug Application to the USFDA with Paragraph IV certification to sell a generic version of Doxycycline Hyclate (Doryx) 150 mg DR tablets.
Earlier news of IPPharmdoc on this product Here
Monday, 4 May 2009
Doxycycline Hyclate (Doryx) 150 mg DR tablets: Innovator sued Mylan
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment